New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 9, 2014
08:58 EDTILMNIllumina not targeted by new Chinese regulations, says Janney Capital
Janney Capital said its contacts in China indicated that a government ban there on genetic testing is intended to protect patients, not domestic vendors, and that CDFA regulation should be irrelevant for Illumina. The firm has a Neutral rating on shares of Illumina.
News For ILMN From The Last 14 Days
Check below for free stories on ILMN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 24, 2014
07:18 EDTILMNIllumina price target raised to $195 from $180 at Leerink
Leerink raised its price target for Illumina shares to $195 citing continued instrument momentum following the company's Q2 results. The firm keeps an Outperform rating on the stock.
July 23, 2014
16:23 EDTILMNIllumina raises FY14 EPS view to $2.26-$2.28 from $2.10-$2.15, consensus $2.17
Subscribe for More Information
16:19 EDTILMNIllumina reports Q2 EPS 57c, consensus 51c
Subscribe for More Information
15:30 EDTILMNNotable companies reporting after market close
Subscribe for More Information
July 21, 2014
06:32 EDTILMNIllumina's NGS selected by Berry Genomics
Subscribe for More Information
July 17, 2014
10:00 EDTILMNOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:20 EDTILMNIllumina initiated with a Buy at Citigroup
Subscribe for More Information
July 16, 2014
06:31 EDTILMNIllumina acquires Myraqa
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use